Cargando…

De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum

ABSTRACT: Indole has an increasing interest in the flavor and fragrance industry. It is used in dairy products, tea drinks, and fine fragrances due to its distinct floral odor typical of jasmine blossoms. The current production of indole based on isolation from coal tar is non-sustainable and its is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mindt, Melanie, Ferrer, Lenny, Bosch, Dirk, Cankar, Katarina, Wendisch, Volker F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006044/
https://www.ncbi.nlm.nih.gov/pubmed/36786915
http://dx.doi.org/10.1007/s00253-023-12397-4
_version_ 1784905225471000576
author Mindt, Melanie
Ferrer, Lenny
Bosch, Dirk
Cankar, Katarina
Wendisch, Volker F.
author_facet Mindt, Melanie
Ferrer, Lenny
Bosch, Dirk
Cankar, Katarina
Wendisch, Volker F.
author_sort Mindt, Melanie
collection PubMed
description ABSTRACT: Indole has an increasing interest in the flavor and fragrance industry. It is used in dairy products, tea drinks, and fine fragrances due to its distinct floral odor typical of jasmine blossoms. The current production of indole based on isolation from coal tar is non-sustainable and its isolation from plants is often unprofitable due to low yields. To offer an alternative to the conventional production, biosynthesis of indole has been studied recently. A glucose-based indole production was achieved by employing the Corynebacterium glutamicum tryptophan synthase α-subunit (TrpA) or indole-3-glycerol phosphate lyase (IGL) from wheat Triticum aestivum in a genetically-engineered C. glutamicum strain. In addition, a highly efficient bioconversion process using C. glutamicum heterologously expressing tryptophanase gene (tnaA) from Providencia rettgeri as a biocatalyst was developed. In this work, de novo indole production from glucose was enabled by expressing the P. rettgeri tnaA in a tryptophan-producing C. glutamicum strain. By metabolic engineering of a C. glutamicum shikimate accumulating base strain, tryptophan production of 2.14 ± 0.02 g L(-1) was achieved. Introduction of the tryptophanase form P. rettgeri enabled indole production, but to low titers, which could be improved by sequestering indole into the water-immiscible solvent tributyrin during fermentation and a titer of 1.38 ± 0.04 g L(-1) was achieved. The process was accelerated by decoupling growth from production increasing the volumetric productivity about 4-fold to 0.08 g L(-1) h(-1). KEY POINTS: • Efficient de novo indole production via tryptophanases from glucose • Increased indole titers by product sequestration and improved precursor supply • Decoupling growth from production accelerated indole production
format Online
Article
Text
id pubmed-10006044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100060442023-03-12 De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum Mindt, Melanie Ferrer, Lenny Bosch, Dirk Cankar, Katarina Wendisch, Volker F. Appl Microbiol Biotechnol Biotechnological Products and Process Engineering ABSTRACT: Indole has an increasing interest in the flavor and fragrance industry. It is used in dairy products, tea drinks, and fine fragrances due to its distinct floral odor typical of jasmine blossoms. The current production of indole based on isolation from coal tar is non-sustainable and its isolation from plants is often unprofitable due to low yields. To offer an alternative to the conventional production, biosynthesis of indole has been studied recently. A glucose-based indole production was achieved by employing the Corynebacterium glutamicum tryptophan synthase α-subunit (TrpA) or indole-3-glycerol phosphate lyase (IGL) from wheat Triticum aestivum in a genetically-engineered C. glutamicum strain. In addition, a highly efficient bioconversion process using C. glutamicum heterologously expressing tryptophanase gene (tnaA) from Providencia rettgeri as a biocatalyst was developed. In this work, de novo indole production from glucose was enabled by expressing the P. rettgeri tnaA in a tryptophan-producing C. glutamicum strain. By metabolic engineering of a C. glutamicum shikimate accumulating base strain, tryptophan production of 2.14 ± 0.02 g L(-1) was achieved. Introduction of the tryptophanase form P. rettgeri enabled indole production, but to low titers, which could be improved by sequestering indole into the water-immiscible solvent tributyrin during fermentation and a titer of 1.38 ± 0.04 g L(-1) was achieved. The process was accelerated by decoupling growth from production increasing the volumetric productivity about 4-fold to 0.08 g L(-1) h(-1). KEY POINTS: • Efficient de novo indole production via tryptophanases from glucose • Increased indole titers by product sequestration and improved precursor supply • Decoupling growth from production accelerated indole production Springer Berlin Heidelberg 2023-02-14 2023 /pmc/articles/PMC10006044/ /pubmed/36786915 http://dx.doi.org/10.1007/s00253-023-12397-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biotechnological Products and Process Engineering
Mindt, Melanie
Ferrer, Lenny
Bosch, Dirk
Cankar, Katarina
Wendisch, Volker F.
De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title_full De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title_fullStr De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title_full_unstemmed De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title_short De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
title_sort de novo tryptophanase-based indole production by metabolically engineered corynebacterium glutamicum
topic Biotechnological Products and Process Engineering
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006044/
https://www.ncbi.nlm.nih.gov/pubmed/36786915
http://dx.doi.org/10.1007/s00253-023-12397-4
work_keys_str_mv AT mindtmelanie denovotryptophanasebasedindoleproductionbymetabolicallyengineeredcorynebacteriumglutamicum
AT ferrerlenny denovotryptophanasebasedindoleproductionbymetabolicallyengineeredcorynebacteriumglutamicum
AT boschdirk denovotryptophanasebasedindoleproductionbymetabolicallyengineeredcorynebacteriumglutamicum
AT cankarkatarina denovotryptophanasebasedindoleproductionbymetabolicallyengineeredcorynebacteriumglutamicum
AT wendischvolkerf denovotryptophanasebasedindoleproductionbymetabolicallyengineeredcorynebacteriumglutamicum